S100A12 (EN-RAGE) in monitoring Kawasaki disease

Lancet

Volumn 361, Issue 9365, 2003, Pages 1270-1272

  Foell, Dirk ^a   Ichida, Fukiko ^b   Vogl, Thomas ^a   Yu, Xianyi ^b   Chen, Rui ^b   Miyawaki, Toshio ^b   Sorg, Clemens ^a   Roth, Johannes ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CALCIUM BINDING PROTEIN; CALGRANULIN; IMMUNOGLOBULIN; PLASMA PROTEIN; PROTEIN S100A12; RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN TARGETING;

EID: 0242500281     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12986-8     Document Type: Article

References (4)

1. Hofmann M.A., Drury S., Fu C., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 97:1999;889-901.
2. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest. 108:2001;949-955.
3. Brogan P.A., Bose A., Burgner D., et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child. 86:2002;286-290.
4. Vogl T., Propper C., Hartmann M., et al. S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14. J Biol Chem. 274:1999;25291-25296.